BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20129690)

  • 1. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.
    Claassen MA; de Knegt RJ; Tilanus HW; Janssen HL; Boonstra A
    J Hepatol; 2010 Mar; 52(3):315-21. PubMed ID: 20129690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection.
    Ward SM; Fox BC; Brown PJ; Worthington J; Fox SB; Chapman RW; Fleming KA; Banham AH; Klenerman P
    J Hepatol; 2007 Sep; 47(3):316-24. PubMed ID: 17475362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.
    Sturm N; Thélu MA; Camous X; Dimitrov G; Ramzan M; Dufeu-Duchesne T; Bonorino P; Guillermet C; Brambilla E; Arvers P; Pernollet M; Leroy V; Zarski JP; Marche PN; Jouvin-Marche E
    J Hepatol; 2010 Jul; 53(1):25-35. PubMed ID: 20452085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection.
    Riezu-Boj JI; Larrea E; Aldabe R; Guembe L; Casares N; Galeano E; Echeverria I; Sarobe P; Herrero I; Sangro B; Prieto J; Lasarte JJ
    J Hepatol; 2011 Mar; 54(3):422-31. PubMed ID: 21129807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
    Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
    Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
    Itose I; Kanto T; Kakita N; Takebe S; Inoue M; Higashitani K; Miyazaki M; Miyatake H; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Viral Hepat; 2009 Dec; 16(12):844-52. PubMed ID: 19486278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
    Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
    Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of circulating CD4+CD25+ and liver-infiltrating Foxp3+ cells in HCV-associated liver disease.
    Amoroso A; D'Amico F; Consolo M; Skarmoutsou E; Neri S; Dianzani U; Spandidos DA; Mazzarino MC
    Int J Mol Med; 2012 Jun; 29(6):983-8. PubMed ID: 22446965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redistribution of regulatory T-cells across the evolving stages of chronic hepatitis C.
    Ferri S; Lalanne C; Lanzoni G; Bassi M; Asioli S; Cipriano V; Pappas G; Muratori P; Lenzi M; Muratori L
    Dig Liver Dis; 2011 Oct; 43(10):807-13. PubMed ID: 21684822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.
    Lan RY; Cheng C; Lian ZX; Tsuneyama K; Yang GX; Moritoki Y; Chuang YH; Nakamura T; Saito S; Shimoda S; Tanaka A; Bowlus CL; Takano Y; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 2006 Apr; 43(4):729-37. PubMed ID: 16557534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.
    Schirren CA; Jung MC; Gerlach JT; Worzfeld T; Baretton G; Mamin M; Hubert Gruener N; Houghton M; Pape GR
    Hepatology; 2000 Sep; 32(3):597-603. PubMed ID: 10960455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of the Regulatory T lymphocytes in hepatitis C fibrosis progression].
    Delhem N; Cottrez F; Carpentier A; Miroux C; Moralès O; François V; Groux H; Auriault C; Pancré V
    Bull Cancer; 2008 Nov; 95(11):1029-38. PubMed ID: 19036674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus infection after liver transplantation is associated with lower levels of activated CD4(+)CD25(+)CD45RO(+)IL-7ralpha(high) T cells.
    Ciuffreda D; Codarri L; Buhler L; Vallotton L; Giostra E; Mentha G; Morel P; Pantaleo G; Pascual M
    Liver Transpl; 2010 Jan; 16(1):49-55. PubMed ID: 19866484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
    Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
    Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of FOXP3 and induction of suppressive function in CD4+ Jurkat T-cells expressing hepatitis C virus core protein.
    Dominguez-Villar M; Fernandez-Ponce C; Munoz-Suano A; Gomez E; Rodríguez-Iglesias M; Garcia-Cozar F
    Clin Sci (Lond); 2012 Jul; 123(1):15-27. PubMed ID: 22214248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.
    Kamal SM; Graham CS; He Q; Bianchi L; Tawil AA; Rasenack JW; Khalifa KA; Massoud MM; Koziel MJ
    J Infect Dis; 2004 Apr; 189(7):1140-50. PubMed ID: 15031780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.
    Xu D; Fu J; Jin L; Zhang H; Zhou C; Zou Z; Zhao JM; Zhang B; Shi M; Ding X; Tang Z; Fu YX; Wang FS
    J Immunol; 2006 Jul; 177(1):739-47. PubMed ID: 16785573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans.
    Claassen MA; de Knegt RJ; Janssen HL; Boonstra A
    J Virol; 2011 Jun; 85(11):5323-30. PubMed ID: 21450832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4⁺ and CD8⁺ regulatory T cells (Tregs) are elevated and display an active phenotype in patients with chronic HCV mono-infection and HIV/HCV co-infection.
    Hartling HJ; Gaardbo JC; Ronit A; Knudsen LS; Ullum H; Vainer B; Clausen MR; Skogstrand K; Gerstoft J; Nielsen SD
    Scand J Immunol; 2012 Sep; 76(3):294-305. PubMed ID: 22671952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of CD4+ CD25+ FoxP3+ regulatory T cells in chronic hepatitis C virus infection.
    Hashempoor T; Bamdad T; Merat S; Janzamin E; Nemati L; Jabbari H; Sharifi AH; Zamini H
    Iran J Immunol; 2010 Sep; 7(3):177-85. PubMed ID: 20876988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.